Financials data is unavailable for this security.
View more
Year on year Guided Therapeutics Inc grew revenues 653.85% from 13.00k to 98.00k while net income improved from a loss of 4.34m to a smaller loss of 3.49m.
Gross margin | 42.11% |
---|---|
Net profit margin | -5,721.05% |
Operating margin | -5,118.42% |
Return on assets | -120.81% |
---|---|
Return on equity | -- |
Return on investment | -- |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Guided Therapeutics Inc fell by 1.72m. Cash Flow from Financing totalled 24.00k or 24.49% of revenues. In addition the company used 1.75m for operations while cash from investing was breakeven.
Cash flow per share | -0.0442 |
---|---|
Price/Cash flow per share | -- |
Book value per share | -0.0829 |
---|---|
Tangible book value per share | -0.0829 |
More ▼
Balance sheet in USDView more
Current ratio | 0.1781 |
---|---|
Quick ratio | 0.0679 |
Total debt/total equity | -- |
---|---|
Total debt/total capital | -- |
More ▼